Recommended

Register now: Enhancing biopharma workflows with the power of UV/Vis spectroscopy webinar
Learn more about leveraging real-world data, the practical applications of AI and adopting configurable LC/NC solutions.
Download this compendium to discover how hot-melt extrusion can help to overcome pharmaceutical formulation challenges
This Guide to Testing explores the limits of detection requirements for microbial testing of short-shelf-life products and sustainable endotoxin testing.
Join this webinar to hear about the latest RMM technology and how it aligns with UPS testing criteria.
article

Issue 4, 2018

A US perspective on how pharma companies are preparing for Brexit, overcoming disinfectant residues with culture media neutralisers, unlocking the potential of new technology in biopharma, and much more in this issue of European Pharmaceutical Review.

European Pharmaceutical Review issue 4 2018

In this issue:

  • REGULATORY INSIGHT: U.S. perspective on the impact of Brexit on the pharmaceutical sector
    Daniel Kracov, Partner and co-chair of Arnold & Porter’s Life Sciences and Healthcare Regulatory practice; Jacqueline Mulryne, Counsel in Arnold & Porter’s London Office and Libby Amos, Associate in Arnold & Porter’s London Office
  • ENVIRONMENTAL MONITORING: Avoiding environmental monitoring ‘false negatives’: overcoming disinfectant residues with culture media neutralisers
    Tim Sandle Head of Microbiology, Bio Products Laboratory
  • PACKAGING: Postponement: the solution for biotech packaging
    Dexter Tjoa, Director Corporate Strategy at Tjoapack
  • QA/QC: Quality Assurance/Pharmaceutical Quality Systems in manufacturing medicinal products
    Anastasia Petropoulu, Radiopharmacy Technician / Clinical Scientist, University Hospital Bristol NHS Foundation Trust
  • BIOPHARMA PROCESSING & DEVELOPMENT: Understanding the importance of diversity of particle size methods
    Edislav Lekšić, Team Leader of Physical Sciences, Almac Group

The digital version of Issue 4 2018 is restricted - login or subscribe free to access

Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here